Insufficient Natriuretic Response to Continuous Intravenous Furosemide Is Associated With Poor Long-Term Outcomes in Acute Decompensated Heart Failure

被引:127
作者
Singh, Dhssraj [1 ]
Shrestha, Kevin [2 ]
Testani, Jeffrey M. [3 ,4 ]
Verbrugge, Frederik H. [5 ,6 ]
Dupont, Matthias [5 ]
Mullens, Wilfried [5 ,6 ]
Tang, W. H. Wilson [2 ]
机构
[1] Univ Kansas, Dept Med, Div Cardiovasc Dis, Kansas City, KS USA
[2] Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, Cleveland, OH 44195 USA
[3] Yale Univ, Univ Sch Med, Dept Internal Med, New Haven, CT USA
[4] Yale Univ, Univ Sch Med, Program Appl Translat Res, New Haven, CT USA
[5] Ziekenhuis Oost Limburg, Dept Cardiol, Genk, Belgium
[6] Hasselt Univ, Doctoral Sch Med & Life Sci, Diepenbeek, Belgium
基金
美国国家卫生研究院;
关键词
Acute decompensated heart failure; furosemide; urine sodium; natriuresis; WORSENING RENAL-FUNCTION; ACUTE KIDNEY INJURY; SERUM CREATININE; DIURETIC THERAPY; BLOOD-PRESSURE; IMPACT;
D O I
10.1016/j.cardfail.2014.03.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Treatment of acute decompensated heart failure (ADHF) with loop diuretics, such as furosemide, is frequently complicated by insufficient urine sodium excretion. We hypothesize that insufficient natriuretic response to diuretic therapy, characterized by lower urine sodium (U-Na) and urine furosemide, is associated with subsequent inadequate decongestion, worsening renal function, and adverse long term events. Methods and Results: We enrolled 52 consecutive patients with ADHF and measured serum and urine sodium (U-Na), urine creatinine (U-Cr), and urine furosemide (U-Furosemide) levels on a spot sample taken after treatment with continuous intravenous furosemide, and followed clinical and renal variables as well as adverse long-term clinical outcomes (death, rehospitalizations, and cardiac transplantation). We observed similar correlations between U-Na:U-Furosemide ratio and U-Na and fractional excretion of sodium (FENa) with 24-hour net urine output (r = 0.52-0.64, all P < .01) and 24-hour weight loss (r = 0.44-0.56; all P < .01). Interestingly, FENa (but not U-Na or U-Na:U-Furosemide) were influenced by estimated glomerular filtration rate (eGFR). We observed an association between lower U-Na:U-Furosemide with greater likelihood of worsening renal function (hazard ratio [HR] 3.01; P = .02) and poorer adverse clinical outcomes (HR 1.63, P = .008) after adjusting for age and eGFR. Meanwhile, both diminished weight loss and net fluid output over 24 hours of continuous intravenous furosemide were observed when U-Na:U-Furosemide ratios were <2 mmol/mg or when U-Na <50 mmol. Conclusion: In patients with ADHF receiving continuous furosemide infusion, impaired natriuretic response to furosemide is associated with greater likelihood of worsening renal function and future adverse long-term outcomes, independently from and incrementally with decreasing intrinsic glomerular filtration.
引用
收藏
页码:392 / 399
页数:8
相关论文
共 23 条
[1]  
Alattar FT, 2010, EXP CLIN CARDIOL, V15, pE65
[2]  
Ali Syed S, 2009, Congest Heart Fail, V15, P1, DOI 10.1111/j.1751-7133.2008.00037.x
[3]   Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome [J].
Bart, Bradley A. ;
Goldsmith, Steven R. ;
Lee, Kerry L. ;
Givertz, Michael M. ;
O'Connor, Christopher M. ;
Bull, David A. ;
Redfield, Margaret M. ;
Deswal, Anita ;
Rouleau, Jean L. ;
LeWinter, Martin M. ;
Ofili, Elizabeth O. ;
Stevenson, Lynne W. ;
Semigran, Marc J. ;
Felker, G. Michael ;
Chen, Horng H. ;
Hernandez, Adrian F. ;
Anstrom, Kevin J. ;
McNulty, Steven E. ;
Velazquez, Eric J. ;
Ibarra, Jenny C. ;
Mascette, Alice M. ;
Braunwald, Eugene .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (24) :2296-2304
[4]   Update in Diuretic Therapy: Clinical Pharmacology [J].
Brater, D. Craig .
SEMINARS IN NEPHROLOGY, 2011, 31 (06) :483-494
[5]   FUROSEMIDE IN PATIENTS WITH HEART-FAILURE - SHIFT IN DOSE-RESPONSE CURVES [J].
BRATER, DC ;
CHENNAVASIN, P ;
SEIWELL, R ;
BECK, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :182-186
[6]  
Brater DC, 1985, WHY IT HAPPENS WHAT, V30, P427, DOI DOI 10.2165/00003495-198530050-00003
[7]   Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment [J].
Dupont, Matthias ;
Mullens, Wilfried ;
Finucan, Michael ;
Taylor, David O. ;
Starling, Randall C. ;
Tang, W. H. Wilson .
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (04) :433-440
[8]   Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure [J].
Dupont, Matthias ;
Shrestha, Kevin ;
Singh, Dhssraj ;
Awad, Adiveh ;
Kovach, Cynthia ;
Scarcipino, Mario ;
Maroo, Anjli P. ;
Tang, W. H. Wilson .
EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (06) :597-604
[9]   Diuretic therapy and resistance in congestive heart failure [J].
Ellison, DH .
CARDIOLOGY, 2001, 96 (3-4) :132-143
[10]   Diuretic Strategies in Patients with Acute Decompensated Heart Failure [J].
Felker, G. Michael ;
Lee, Kerry L. ;
Bull, David A. ;
Redfield, Margaret M. ;
Stevenson, Lynne W. ;
Goldsmith, Steven R. ;
LeWinter, Martin M. ;
Deswal, Anita ;
Rouleau, Jean L. ;
Ofili, Elizabeth O. ;
Anstrom, Kevin J. ;
Hernandez, Adrian F. ;
McNulty, Steven E. ;
Velazquez, Eric J. ;
Kfoury, Abdallah G. ;
Chen, Horng H. ;
Givertz, Michael M. ;
Semigran, Marc J. ;
Bart, Bradley A. ;
Mascette, Alice M. ;
Braunwald, Eugene ;
O'Connor, Christopher M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09) :797-805